title: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
abstract: BACKGROUND
  Cancer incidence and mortality estimates for 25 cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for the European Union (EU-27) for 2012.
  
  
  METHODS
  We used statistical models to estimate national incidence and mortality rates in 2012 from recently-published data, predicting incidence and mortality rates for the year 2012 from recent trends, wherever possible. The estimated rates in 2012 were applied to the corresponding population estimates to obtain the estimated numbers of new cancer cases and deaths in Europe in 2012.
  
  
  RESULTS
  There were an estimated 3.45 million new cases of cancer (excluding non-melanoma skin cancer) and 1.75 million deaths from cancer in Europe in 2012. The most common cancer sites were cancers of the female breast (464,000 cases), followed by colorectal (447,000), prostate (417,000) and lung (410,000). These four cancers represent half of the overall burden of cancer in Europe. The most common causes of death from cancer were cancers of the lung (353,000 deaths), colorectal (215,000), breast (131,000) and stomach (107,000). In the European Union, the estimated numbers of new cases of cancer were approximately 1.4 million in males and 1.2 million in females, and around 707,000 men and 555,000 women died from cancer in the same year.
  
  
  CONCLUSIONS
  These up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe. The important role of cancer registries in disease surveillance and in planning and evaluating national cancer plans is becoming increasingly recognised, but needs to be further advocated. The estimates and software tools for further analysis (EUCAN 2012) are available online as part of the European Cancer Observatory (ECO) (http://eco.iarc.fr).
authors.affiliation: Section of Cancer Information, International Agency for Research on Cancer (IARC), France. ferlayj@iarc.fr
authors.forename: J
authors.initials: J
authors.lastname: Ferlay
authors.forename: E
authors.initials: E
authors.lastname: Steliarova-Foucher
authors.forename: J
authors.initials: J
authors.lastname: Lortet-Tieulent
authors.forename: S
authors.initials: S
authors.lastname: Rosso
authors.forename: J W W
authors.initials: JW
authors.lastname: Coebergh
authors.forename: H
authors.initials: H
authors.lastname: Comber
authors.forename: D
authors.initials: D
authors.lastname: Forman
authors.forename: F
authors.initials: F
authors.lastname: Bray
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology / Q000401:mortality; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000401:mortality; D005060:Europe / Q000453:epidemiology; D005062:European Union / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000453:epidemiology / Q000401:mortality; D008297:Male; D009026:Mortality / Q000639:trends*; D009369:Neoplasms / Q000453:epidemiology* / Q000401:mortality*; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000401:mortality; D012042:Registries / Q000706:statistics & numerical data*; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000401:mortality; D015996:Survival Rate / Q000639:trends